People often talk about cannabis as though it were harmless, something users simply grow out of. The clinical picture looks very different, and much of it comes down to strength.

Over the past three decades, high-potency cannabis has taken over the market, and doctors have watched cases of cannabis-induced psychosis climb alongside it. This is not mild paranoia after a joint. It is a severe break from reality, involving delusions, and sometimes hallucinations, that can land someone in an emergency department.

A recent review in Frontiers in Psychiatry pulled together case reports, hospital data and neurobiological studies spanning several decades. Read together, they make a hard case for why strong cannabis, and the psychosis it can trigger, needs far more attention than it currently gets.

What Does High-Potency Cannabis Do to the Brain?

Cannabis-induced psychosis describes an acute break from reality that can follow heavy use of strong cannabis. Family members and friends often describe a noticeable shift in a loved one’s thinking and behaviour beforehand, including paranoid thoughts, delusional beliefs, or hearing voices that are not there.

Reviewing a series of significant, unexpected violent incidents from mainstream media, researchers found recurring warning signs: individuals removing their clothing in public, becoming disoriented, or acting in ways completely out of character in the days or weeks before the event. In many of these cases, toxicology testing confirmed THC as the only substance present, and in several instances doctors had already diagnosed the individual with cannabis-induced psychosis before the violence occurred.

What makes this especially concerning is the long-term trajectory. Among all substance-induced psychoses, cannabis carries the highest documented rate of conversion to a lasting schizophrenia diagnosis; researchers put the rate at between thirty-four and forty-seven percent depending on the study.

A large meta-analysis of fifty studies covering more than 40,000 individuals found that thirty-four percent of cannabis-induced psychosis cases went on to develop schizophrenia, compared with just ten percent for alcohol-induced psychosis, nine percent for sedatives, and twelve percent for opioids. Danish registry data told a similarly stark story: doctors later diagnosed 47.4 percent of people who had cannabis-induced psychosis with schizophrenia or bipolar disorder, and half of those schizophrenia diagnoses arrived within just 3.1 years of the first psychotic episode.

An Ontario study tracking 9.8 million people found that anyone who presented to an emergency department with cannabis-induced psychosis was eighty-four times more likely to later receive a schizophrenia diagnosis than the general population. Among boys and young men aged fourteen to eighteen who experienced this, more than forty percent went on to develop schizophrenia during the follow-up period.

Why High-Potency Cannabis Has Become the Norm

The Rise of High-Potency Cannabis

The cannabis available today bears little resemblance to the cannabis of previous generations. Through the 1960s to the 1980s, cannabis flower typically contained between two and four percent THC. Today, flower on the market in parts of the United States averages around twenty percent THC, and concentrates can reach eighty to ninety percent. In 2022, seventy-one percent of the dried cannabis in Canada’s legal market exceeded twenty percent THC.

A 2025 systematic review of ninety-nine studies involving 221,097 participants confirmed that high-potency cannabis carries a consistent, unfavourable link to psychosis and schizophrenia. Daily users of cannabis above ten percent THC face roughly five times the risk of psychotic disorder compared with people who have never used cannabis, and the relationship follows a clear dose-response pattern: the stronger the product and the more frequent the use, the greater the risk.

Adolescent Vulnerability

Young people are especially vulnerable. A large Canadian study of 11,363 youth found that cannabis use between the ages of twelve and nineteen raised the risk of a psychotic disorder 11.2-fold. When researchers looked specifically at the most severe outcomes, those requiring hospitalisation or emergency care, that risk climbed to 26.7 times higher than among non-users.

Strikingly, researchers did not observe this heightened risk in young adults aged twenty to thirty-three, pointing to adolescence as a distinct window of neurodevelopmental vulnerability. In the same study, 77.8 percent of adolescent hospitalisations for psychotic disorders occurred in young people who had used cannabis in the past year.

Cannabis use at age fifteen or younger showed a particularly strong link to later psychotic disorder, consistent with the idea that the still-developing adolescent brain is more susceptible to disruption from strong cannabis, although researchers caution that shared genetic vulnerability may also play a role.

The Biology Behind the Risk

The biological explanation for this vulnerability is becoming clearer. THC acts on CB1 receptors concentrated in the prefrontal cortex, hippocampus and basal ganglia, regions still undergoing significant rewiring during adolescence through processes such as synaptic pruning and myelination.

Animal studies suggest that exposure to strong cannabis during this developmental window may disrupt these processes and alter the balance between excitatory and inhibitory brain signalling, affecting memory, executive function and sensory processing in ways that echo schizophrenia’s deficits.

A 2025 neuroimaging study using neuromelanin-sensitive MRI, a proxy for dopamine activity, found that people with cannabis use disorder showed elevated signal in brain regions that drive psychosis, and signal strength rose alongside symptom severity. This offers a plausible biological pathway connecting heavy use of high-potency cannabis to the same dopamine dysfunction that occurs in schizophrenia.

Psychosis During Withdrawal

Cannabis psychosis does not occur only during periods of active use. A 2025 systematic review identified 112 documented cases of psychosis that cannabis withdrawal triggered, typically emerging within a week of stopping use and peaking around day four in daily users. Sleep disturbance was present in ninety percent of these cases.

Individuals who returned to cannabis use after withdrawal-related psychosis faced nearly fourteen times the risk of relapse compared with those who remained abstinent, a finding that underscores just how disruptive cannabis can be to the brain’s stability even after use stops.

High-Potency Cannabis After Legalisation

Jurisdictions that have legalised cannabis have recorded measurable increases in cannabis-related hospital presentations, as high-potency cannabis products have become widely and legally available. Following recreational legalisation in Canada in October 2018, emergency department visits for cannabis-induced psychosis rose by roughly forty percent during the period researchers tracked from 2010 to 2022, with the sharpest increases among young adults aged nineteen to twenty-four.

In Massachusetts, cannabis use increased once retail outlets opened following legalisation. A Denver Health study examining psychosis hospitalisations between 2005 and 2020 found youth hospitalisation rates for psychosis rose from 21.9 per 100,000 before legalisation to 32.3 per 100,000 afterwards. For hospitalisations specifically involving cannabis use disorder, the rate nearly quadrupled, climbing from 2.0 to 7.9 per 100,000.

High-Potency Cannabis and the Path to Violence

The hardest part of this research to sit with is the link between cannabis-induced psychosis and violent behaviour. Violence is rare, both among people who use cannabis and among people who have schizophrenia. But among those with schizophrenia, persistent use of cannabis stands out as an independent risk factor for violence.

One study following 965 patients over time found that ongoing cannabis use predicted later violent behaviour, while violence did not predict later cannabis use, a one-directional relationship that held even after accounting for alcohol and stimulant use.

A separate long-term study of 1,136 psychiatric patients who had recently left hospital found that people who used cannabis consistently across all four follow-up assessments were 2.44 times more likely to display violent behaviour than non-users, a stronger association than researchers found for either alcohol or cocaine. The relationship followed a clear dose-response pattern: occasional cannabis users showed a three percent rate of violence, regular users six percent, and frequent users eleven percent. Each step up in frequency of use raised the odds of violent behaviour 1.91-fold.

Cannabis-induced psychosis itself carries a particularly high risk profile. Among people experiencing this condition, violence rates reached seventy-seven percent when impulsivity accompanied the psychosis, and between fifty-three and fifty-eight percent when patients also lacked insight into their condition and skipped their medication.

Young adults with daily cannabis use showed 1.7 to 1.8 times higher rates of violence among males and 1.6 to 2.4 times higher among females compared with non-users, while persistent cannabis use across the lifespan raised the odds of a violent conviction sevenfold.

The pattern extends beyond civilian populations. A study of 3,028 veterans of the Iraq and Afghanistan conflicts found that those with current cannabis use disorder were significantly more likely to report difficulty managing anger, aggressive impulses and problems controlling violent behaviour. Among veterans with cannabis use disorder, twenty-seven percent reported difficulty controlling violence in the previous month, compared with just eight percent of veterans without the disorder.

Researchers who reviewed high-profile violent incidents in the media found a consistent picture: people no one had previously flagged as a risk suddenly carried out serious acts of violence, often involving weapons, after weeks of gradually worsening paranoia or delusional thinking. Family and friends had usually noticed these changes but had not always recognised them as a medical emergency.

A significant limitation the researchers highlight is that toxicology testing for THC varies inconsistently across the country. Some jurisdictions do not routinely test for cannabinoids in violent deaths at all, others restrict the release of results to next of kin or under court order, and at least one state protects such results from disclosure for fifty years. This means the data likely under-record the true scale of cannabis-related violence rather than overstate it.

Reducing the Risk of High-Potency Cannabis

Given the heightened vulnerability of adolescents and young adults, prevention remains the most effective response. Delaying any cannabis exposure until the brain has finished developing, steering clear of high-potency products altogether, and recognising early warning signs such as withdrawal symptoms, sleep disruption or emerging paranoia can help families and communities intervene before a crisis develops.

Researchers behind the review suggest that simply asking why a person began using cannabis, whether to cope with anxiety, low mood or physical discomfort, can serve as a useful early screening question, since those who begin using cannabis for self-medication tend to show heavier use and more severe paranoia and mood symptoms than those who begin for social reasons.

The researchers encourage healthcare providers to routinely screen for cannabis use in young patients and those with existing mental health conditions, and to provide clear, evidence-based education about the psychiatric risks involved.

Where cannabis-induced psychosis does occur, treatment typically centres on complete abstinence from cannabis alongside antipsychotic medication. A Thai study of 317 patients with cannabis-induced psychosis found that doctors treated 98.7 percent with antipsychotics, with meaningful symptom improvement evident by day eight and continued improvement through to day twenty-eight. Long-term follow-up remains essential for anyone who has experienced an episode, given how frequently it progresses to a lasting schizophrenia diagnosis.

High-Potency Cannabis Deserves to Be Taken Seriously

Cannabis is getting stronger and easier to get hold of. At the same time, the case linking high-potency cannabis to long-term mental illness and to violence keeps getting harder to dismiss.

Treating cannabis as a harmless pastime does not match what the evidence shows, particularly for adolescents, whose risk is not just higher but dramatically so.

More consistent toxicology testing, earlier screening in GP surgeries and clinics, and simply making people aware of what high-potency cannabis can do would go a long way. Right now, there is a real gap between what the research shows and what most families understand.

Source: Frontiers